Sharon Liang

Company: Bristol Myers Squibb

Job title: Executive Director, Head, Precision Medicine & Digital Health

Seminars:

Precision Medicine Strategic Considerations for Global Market Access: From Early CDx Development to Clinical Trials & Overcoming Regulatory Hurdles 8:30 am

Understanding regulatory considerations for USA, EU and APAC to expedite approvals Creating a robust CDx strategy to expedite from clinical trials through to CDx launch Key considerations for diagnostic tests in clinical trials and using this data for global submissionsRead more

day: Conference Day 1 AM

Panel Discussion: Streamlining Regulatory Approaches to Optimize CDx Development, Reduce Complexities & Allow Patients Timely Access to Drug-Diagnostics Clinical Trials 9:30 am

Given the fragmentation of regulatory requirements, will it be more beneficial to stakeholders to harmonise across APAC or will this create friction? Is there a future for there to be one solution that covers all regions to increase harmonisation and enable broader knowledge sharing between countries? Understanding different registration requirements across the region to increase…Read more

day: Conference Day 2